This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Irvith M Carvajal: Innovator in Biopharmaceuticals
Introduction
Irvith M Carvajal is a notable inventor in the field of biopharmaceuticals. He has made significant contributions to medical science through his innovative work. His expertise and dedication have led to advancements that may improve patient outcomes.
Latest Patents
Irvith holds a patent for "Glypican-3-Binding Fibronectin Based Scaffold Molecules." This invention showcases his ability to create novel solutions in the realm of therapeutic applications. The patent reflects his commitment to addressing complex medical challenges.
Career Highlights
Irvith is currently associated with Bristol-Myers Squibb Company, a leading biopharmaceutical firm. His role at the company allows him to leverage his skills and knowledge in developing groundbreaking therapies. His work contributes to the company's mission of discovering and delivering innovative medicines.
Conclusion
Irvith M Carvajal is a distinguished inventor whose work in biopharmaceuticals is paving the way for future innovations. His patent and contributions to Bristol-Myers Squibb Company highlight his impact on the industry. His dedication to improving healthcare through innovation is commendable.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile